Wird geladen...

Biologic targeting in the treatment of inflammatory bowel diseases

The etiology of inflammatory bowel disease (IBD) has not yet been clarified and immunosuppressive agents which nonspecifically reduce inflammation and immunity have been used in the conventional therapies for IBD. Evidence indicates that a dysregulation of mucosal immunity in the gut of IBD causes a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Bosani, Matteo, Ardizzone, Sandro, Porro, Gabriele Bianchi
Format: Artigo
Sprache:Inglês
Veröffentlicht: Dove Medical Press 2009
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2726060/
https://ncbi.nlm.nih.gov/pubmed/19707398
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!